Drug Release from Gelsolin-Targeted Phase-Transition Nanoparticles Triggered by Low-Intensity Focused Ultrasound

References

• Yi S, Zheng J, Lv P, et al. Controlled drug release from cyclodextrin-gated mesoporous silica nanoparticles based on switchable host-guest interactions. Bioconjug Chem. 2018;29(9):2884–2891. doi:10.1021/acs.bioconjchem.8b00416
   PubMed Web of Science ®Google Scholar
• Cheng YJ, Zhang AQ, Hu JJ, He F, Zeng X, Zhang XZ. Multifunctional peptide-amphiphile end-capped mesoporous silica nanoparticles for tumor targeting drug delivery. ACS Appl Mater Interfaces. 2017;9(3):2093–2103. doi:10.1021/acsami.6b12647
   PubMed Web of Science ®Google Scholar
• Shen Y, Li M, Liu T, et al. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells. Int J Nanomedicine. 2019;31(14):4029–4044. doi:10.2147/IJN.S201688
   Web of Science ®Google Scholar
• Luo W, Wen G, Yang L, et al. Dual-targeted and pH-sensitive doxorubicin prodrug-microbubble complex with ultrasound for tumor treatment. Theranostics. 2017;7(2):452–465. doi:10.7150/thno.16677
   PubMed Web of Science ®Google Scholar
• Keum DH, Mun JH, Hwang BW, et al. Smart microbubble eluting theranostic stent for noninvasive ultrasound imaging and prevention of restenosis. Small. 2017;13(10):1602925. doi:10.1002/smll.201602925
   Web of Science ®Google Scholar
• Chertok B, Langer R, Anderson DG. Spatial control of gene expression by nanocarriers using heparin masking and ultrasound-targeted microbubble destruction. ACS Nano. 2016;10(8):7267–7278. doi:10.1021/acsnano.6b01199
   PubMed Web of Science ®Google Scholar
• Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol. 2000;35(1):58–71. doi:10.1097/00004424-200001000-00007
   PubMed Web of Science ®Google Scholar
• Karimi M, Zangabad PS, Mehdizadeh F, et al. Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger. Nanoscale. 2017;9(4):1356–1392. doi:10.1039/c6nr07315h
   PubMed Web of Science ®Google Scholar
• Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 2016;116(4):2602–2663. doi:10.1021/acs.chemrev.5b00346
   PubMed Web of Science ®Google Scholar
• Xue L, Maihle NJ, Yu X, Tang SC, Liu HY. Synergistic targeting HER2 and EGFR with bivalent aptamer-siRNA chimera efficiently inhibits HER2-positive tumor growth. Mol Pharm. 2018;15(11):4801–4813. doi:10.1021/acs.molpharmaceut.8b00388
   PubMed Web of Science ®Google Scholar
• Cao Y, Liu F, Chen Y, et al. Drug release from core-shell PVA/silk fibroin nanoparticles fabricated by one-step electrospraying. Sci Rep. 2017;7(1):11913. doi:10.1038/s41598-017-12351-1
   PubMed Web of Science ®Google Scholar
• Xu H, Zhang D, Li J. Antibacterial nanoparticles with universal adhesion function based on dopamine and eugenol. J Bioresources Bioproducts. 2019;4(3):177–182.
   Google Scholar
• Huang H, Mao L, Li Z, et al. Multifunctional polypyrrole-silver coated layered double hydroxides embedded into a biodegradable polymer matrix for enhanced antibacterial and gas barrier properties. J Bioresources Bioproducts. 2019;4(4):231–241.
   Google Scholar
• Sanchez-Moreno P, Ortega-Vinuesa JL, Peula-Garcia JM, Marchal JA, Boulaiz H. Smart drug-delivery systems for cancer nanotherapy. Curr Drug Targets. 2018;19(4):339–359. doi:10.2174/1389450117666160527142544
   PubMed Web of Science ®Google Scholar
• Shahbaz SK, Foroughi F, Soltaninezhad E, Jamialahmadi T, Penson PE, Sahebkar A. Application of PLGA nano/microparticle delivery systems for immunomodulation and prevention of allotransplant rejection. Expert Opin Drug Deliv. 2020;17(6):767–780. doi:10.1080/17425247.2020.1748006
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chang YQ, Han L, et al. Aptamer-anchored di-polymer shell-capped mesoporous carbon as a drug carrier for bi-trigger targeted drug delivery. J Mater Chem B. 2017;5(33):6882–6889. doi:10.1039/C7TB01528C
   PubMed Web of Science ®Google Scholar
• Chen Z, Sun M, Luo F, Xu K, Lin Z, Zhang L. Stimulus-response click chemistry based aptamer-functionalized mesoporous silica nanoparticles for fluorescence detection of thrombin. Talanta. 2018;178:563–568. doi:10.1016/j.talanta.2017.09.043
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang S, Zhang D, Bai X, Hecht SM, Chen S. DNA-affibody nanoparticles for inhibiting breast cancer cells overexpressing HER2. Chem Commun (Camb). 2017;53(3):573–576. doi:10.1039/C6CC08495H
   PubMed Web of Science ®Google Scholar
• Shao F, Zhang L, Jiao L, et al. Enzyme-free immunosorbent assay of prostate specific antigen amplified by releasing pH indicator molecules entrapped in mesoporous silica nanoparticles. Anal Chem. 2018;90(14):8673–8679. doi:10.1021/acs.analchem.8b02019
   PubMed Web of Science ®Google Scholar
• Xie Y, Bagby TR, Cohen MS, Forrest ML. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies. Expert Opin Drug Deliv. 2009;6(8):785–792. doi:10.1517/17425240903085128
   PubMed Web of Science ®Google Scholar
• Wu J, Meng JY, Du Y, et al. RACK1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1 signaling pathway. Biomed Pharmacother. 2013;67(5):313–319. doi:10.1016/j.biopha.2013.01.011
   PubMed Web of Science ®Google Scholar
• Serrels B, Sandilands E, Serrels A, et al. A complex between FAK, RACK1, and PDE4D5 controls spreading initiation and cancer cell polarity. Curr Biol. 2010;20(12):1086–1092. doi:10.1016/j.cub.2010.04.042
   PubMed Web of Science ®Google Scholar
• Chan MW, Arora PD, Bozavikov P, McCulloch CA. FAK, PIP5KIgamma and gelsolin cooperatively mediate force-induced expression of alpha-smooth muscle actin. J Cell Sci. 2009;122(Pt 5):2769–2781. doi:10.1242/jcs.044008
   PubMed Web of Science ®Google Scholar
• Qazi AS, Sun M, Huang Y, Wei Y, Tang J. Subcellular proteomics: determination of specific location and expression levels of lymphatic metastasis associated proteins in hepatocellular carcinoma by subcellular fractionation. Biomed Pharmacother. 2011;65(6):407–416. doi:10.1016/j.biopha.2011.04.028
   PubMed Web of Science ®Google Scholar
• Shieh DB, Godleski J, Herndon JE, et al. Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression. Cancer. 1999;85(1):47–57. doi:10.1002/(SICI)1097-0142(19990101)85:1<47::AID-CNCR7>3.0.CO;2-L
   PubMed Web of Science ®Google Scholar
• Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D. Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci. 2004;61(19–20):2614–2623. doi:10.1007/s00018-004-4225-6
   PubMed Web of Science ®Google Scholar
• Van Den Abbeele A, De Corte V, Van Impe K, et al. Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro. Cancer Lett. 2007;255(1):57–70. doi:10.1016/j.canlet.2007.03.023
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang Z, Chen Y, et al. Microbubbles from gas-generating perfluorohexane nanoemulsions for targeted temperature-sensitive ultrasonography and synergistic HIFU ablation of tumors. Adv Mater. 2013;25(30):4123–4130. doi:10.1002/adma.201301655
   PubMed Web of Science ®Google Scholar
• Wang R, Zhou Y, Zhang P, et al. Phase-transitional Fe3O4/perfluorohexane microspheres for magnetic droplet vaporization. Theranostics. 2017;7(4):846–854. doi:10.7150/thno.17251
   PubMed Web of Science ®Google Scholar
• Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst. 2007;99(14):1095–1106. doi:10.1093/jnci/djm043
   PubMed Web of Science ®Google Scholar
• Wilson K, Homan K, Emelianov S. Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging. Nat Commun. 2012;3:618. doi:10.1038/ncomms1627
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Zhang M, Wong HL, et al. Prevent diabetic cardiomyopathy in diabetic rats by combined therapy of aFGF-loaded nanoparticles and ultrasound-targeted microbubble destruction technique. J Control Release. 2016;223:11–21. doi:10.1016/j.jconrel.2015.12.030
   PubMed Web of Science ®Google Scholar
• Chen S, Grayburn PA. Ultrasound-targeted microbubble destruction for cardiac gene delivery. Methods Mol Biol. 2017;1521:205–218.
   PubMedGoogle Scholar
• Song Y, Huang Z, Xu J, et al. Multimodal SPION-CREKA peptide based agents for molecular imaging of microthrombus in a rat myocardial ischemia-reperfusion model. Biomaterials. 2014;35(9):2961–2970. doi:10.1016/j.biomaterials.2013.12.038
   PubMed Web of Science ®Google Scholar
• Peña-Bahamonde J, Nguyen HN, Fanourakis SK, Rodrigues DF. Recent advances in graphene-based biosensor technology with applications in life sciences. J Nanobiotechnology. 2018;16(1):75. doi:10.1186/s12951-018-0400-z
   PubMed Web of Science ®Google Scholar
• Liu J, Pu H, Liu S, Kan J, Jin C. Synthesis, characterization, bioactivity and potential application of phenolic acid grafted chitosan: a review. Carbohydr Polym. 2017;174:999–1017. doi:10.1016/j.carbpol.2017.07.014
   PubMed Web of Science ®Google Scholar
• Rapoport NY, Kennedy AM, Shea JE, Scaife CL, Nam KH. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release. 2009;138(3):268–276. doi:10.1016/j.jconrel.2009.05.026
   PubMed Web of Science ®Google Scholar